Speculative investors answer their own questions and understand the level of risks with the variance in accuracy and pay pennies to the dollar, whereas institutional investors pay top dollar to have the questions answered for them where the only risk is not being able to afford the target number of shares.
No one is claiming AMFE has limited the number of questions outstanding. In fact, quite the opposite. We speculative investors claim AMFE a feeding frenzy as shares are dirt cheap. Even the claims against AMFE are designed solely to get shareholders to sell to the bid. We speculative investors make claims for and against the companies we buy. I happen to make claims based on facts and evidence available to the public and pay pennies to the dollar ahead of revenue PRs. Not sure where the claims against AMFE are coming from but am loving the cheapies!
News 
Market Data 
Discover 
AI
